AIM
GWPH

Acrospire Investment Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Acrospire Investment Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-200
Closed -$18K – 2249
2016
Q2 		$18K Sell
200
-200
-50% -$16.8K 0.01% 1571
2016
Q1 		$29K Buy
+400
New +$21.9K 0.02% 1343

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Acrospire Investment Management's GWPH Position: Q3 2016 in Review

Acrospire Investment Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2016, closing a stake of 200 shares — an estimated $18K sold.

Acrospire Investment Management first reported a position in GWPH in Q1 2016 and held it in 2 quarters. The position peaked at $29K in Q1 2016. 138 funds tracked by Wall St. Rank hold GWPH as of Q3 2016.

  • Acrospire Investment Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2016 after selling out during the quarter.
  • Acrospire Investment Management sold 200 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2016, an estimated $18K.
  • Acrospire Investment Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2016 and held it in 2 quarters.
  • Acrospire Investment Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $29K in Q1 2016.
  • 138 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2016.

Based on Acrospire Investment Management's 13F filing for Q3 2016, filed 10 Nov 2016.